The Lupus Knows No Boundaries e-Report brings together firsthand experiences of people with lupus, their advocates and those who treat them, to tell the real story of lupus, highlighting the ongoing physical and emotional needs of those who are affected by this incurable disease.
ImmuPharma PLC (LON:IMM) is a drug discovery and development company. The Company is focused on the development of drugs, primarily based on peptide therapeutics, to treat serious medical conditions such as autoimmune diseases. The Company has approximately five drug candidates in development, over two platform technologies and approximately 70 patents.